Back to search
FDAFDA · Food and drugs·Recall number D-0531-2024

EYLEA, (aflibercept) Injection, For Intravitreal injection, 2 mg (0.05mL of a 40mg/mL solution), Single-dose Pre-filled Glass Syringe, Rx only, Manufactured by: Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY 10591, NDC 61755-005-01, NDC (sample lot) 61755-005-54

Published June 5, 2024 · Recall initiated: May 15, 2024

Summary

FDA records drug Class II recall D-0531-2024, published June 5, 2024 and initiated May 15, 2024. Recalling firm: Regeneron Pharmaceuticals Inc; Status: Terminated; Reported quantity: 405,725 Prefilled syringes; Lot: Lot # 8231500321, Exp. date Oct-24 8231500335, Exp. date Jan-25 8231500333, Exp. date Jan-25 8231500334, Exp. date Jan-25 8231500339, Exp. date Jan-25 8231500347, Exp. date Jan-25 8231500336, Exp. date Jan-25 8231500337, Exp. date Jan-25 8231500340, Exp. date Jan-25 8268700014 (sample lot) exp. date Jan-25. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: Complaints of syringe breakage

What to do

Voluntary: Firm initiated · Letter

Get an email if EYLEA has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
EYLEA
Manufacturer
Regeneron Pharmaceuticals Inc
Distributor
USA nationwide.
UPC
258231500336
Lot
Lot # 8231500321, Exp. date Oct-24 8231500335, Exp. date Jan-25 8231500333, Exp. date Jan-25 8231500334, Exp. date Jan-25 8231500339, Exp. date Jan-25 8231500347, Exp. date Jan-25 8231500336, Exp. date Jan-25 8231500337, Exp. date Jan-25 8231500340, Exp. date Jan-25 8268700014 (sample lot) exp. date Jan-25
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was EYLEA, (aflibercept) Injection, For Intravitreal injection, 2 mg (0.05mL of a 40mg/mL solution), Single-dose Pre-filled Glass Syringe, Rx only, Manufactured by: Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY 10591, NDC 61755-005-01, NDC (sample lot) 61755-005-54 recalled?

Yes. FDA published recall D-0531-2024 on June 5, 2024. Reported hazard: Lack of Assurance of Sterility: Complaints of syringe breakage

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: EYLEA. UPC: 258231500336.